HealthEquity Reports Second Quarter Ended July 31, 2015 Financial Results

Highlights of the second quarter include:

  • Revenue of $30.5 million, an increase of 46% compared to Q2 FY15.
  • Net income of $4.4 million, an increase of 46% compared to Q2 FY15.
  • Net income per diluted share of $0.08 compared to $0.06 in Q2 FY15.
  • Adjusted EBITDA of $11.1 million, an increase of 62% compared to Q2 FY15.
  • Pro forma non-GAAP EPS of $0.09 per share compared to $0.07 in Q2 FY15.
  • HSA Members grew to 1.5 million, an increase of 45% compared to Q2 FY15.
  • Total AUM grew to $2.6 billion, a 47% increase compared to Q2 FY15.
  • Increase in FY16 revenue guidance.

DRAPER, Utah, Sept. 8, 2015 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ:HQY), one of the largest health savings account (“HSA”) non-bank custodians, today announced financial results for its second quarter ended July 31, 2015.

Commenting on the quarter, Jon Kessler, President and CEO of HealthEquity, stated, “HealthEquity has experienced two very solid quarters so far this year and I’m very optimistic about the progress to come during the rest of fiscal 2016. In the second quarter, our revenue grew 46% and our adjusted EBITDA increased 62% year over year, demonstrating strong margin expansion. We grew our HSA membership and assets under management at a robust pace. Our technology, ecosystem, and exemplary levels of customer service continue to differentiate HealthEquity in the fast-growing HSA market and have allowed us to gain market share over the last year.”

Second quarter financial results

For the second quarter ended July 31, 2015, HealthEquity reported revenue of $30.5 million, compared to $20.9 million for the second quarter ended July 31, 2014, an increase of 46%. Revenue consisted primarily of:

  • Account fee revenue of $14.6 million, an increase of 38% compared to Q2 FY15.
  • Custodial fee revenue of $9.0 million, an increase of 52% compared to Q2 FY15.
  • Card fee revenue of $6.8 million, an increase of 60% compared to Q2 FY15.

Net income was $4.4 million for the second quarter ended July 31, 2015, compared to $3.0 million for the second quarter ended July 31, 2014.

Net income per share attributable to diluted common share was $0.08 for the second quarter ended July 31, 2015, compared to $0.06 for the second quarter ended July 31, 2014. Pro forma non-GAAP EPS for the second quarter ended July 31, 2015 was $0.09, compared to $0.07 for the second quarter ended July 31, 2014.

Adjusted EBITDA was $11.1 million for the second quarter ended July 31, 2015, an increase of 62% compared to $6.9 million for the second quarter ended July 31, 2014. Adjusted EBITDA was 36% of revenue for the second quarter ended July 31, 2015, compared to 33% for the second quarter ended July 31, 2014.

As of July 31, 2015, we had $148.9 million of cash, cash equivalents and marketable securities and no outstanding debt. This compares to $111.0 million in cash and cash equivalents and no outstanding debt as of January 31, 2015.

HSA Member and AUM metrics

The total number of HSAs for which we serve as a non-bank custodian (“HSA Members”) as of July 31, 2015 was 1.5 million, an increase of 45% from 1.1 million as of July 31, 2014.

Total assets under management (“AUM”) as of July 31, 2015 was $2.6 billion, an increase of 47% year over year, comprised of:

  • Cash AUM of $2.3 billion, an increase of 46% compared to July 31, 2014; and
  • Investment AUM of $372.1 million, an increase of 56% compared to July 31, 2014.

Investment AUM was 14% of total AUM as of July 31, 2015, compared to 13% as of July 31, 2014.

Business outlook

For the year ended January 31, 2016, we are increasing our expected revenue to be between $120.0 million and $124.0 million. We are maintaining our Adjusted EBITDA to be between $36.0 million and $38.0 million. We expect our pro forma non-GAAP earnings per diluted share to be between $0.28 and $0.30 per share. Our pro forma non-GAAP earnings per diluted share is based on an estimated 60 million weighted-average shares outstanding, and is calculated by adding back to net income all non-cash stock compensation expense, net of tax. We expect total stock compensation expense, net of tax, for the year ended January 31, 2016 to be between $3.5 million and $4.0 million. The business outlook for the year ended January 31, 2016 assumes a projected effective tax rate of approximately 37%.

Conference call

HealthEquity management will host a conference call at 5:00 pm (Eastern Time) on Tuesday, September 8, 2015 to discuss the second quarter financial results. The conference call will be accessible by dialing 888-438-5453, or 719-457-2627 for international callers, and referencing conference ID 7067718. A live webcast of the conference call will also be available on the investor relations section of the company’s website at www.HealthEquity.com.

An audio replay will be available following the conclusion of the call through October 8, 2015. The replay can be accessed by dialing 888-203-1112 in the U.S., or 719-457-0820 for international callers. The passcode for the replay is: 7067718.

Non-GAAP financial information

To supplement our financial information presented on a GAAP basis, we disclose Adjusted EBITDA, pro forma non-GAAP earnings per diluted share, non-GAAP gross profit, non-GAAP gross margin, non-GAAP income from operations, and non-GAAP operating margin, which are non-GAAP financial measures. We define Adjusted EBITDA as adjusted earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, and other certain non-operating items. We define pro forma non-GAAP earnings per diluted share as net income per diluted share, calculated by adding back to net income non-cash stock-based compensation expense, net of tax, and to give effect to the conversion of all our outstanding convertible preferred stock and redeemable convertible preferred stock into common stock, which occurred on August 4, 2014 in connection with our initial public offering, as if such conversion occurred at the beginning of the fiscal year. Non-GAAP gross profit is calculated by excluding from gross profit stock-based compensation expense attributable to cost of services. Non-GAAP gross margin is the ratio calculated by dividing non-GAAP gross profit by revenues. Non-GAAP income from operations is calculated by excluding stock-based compensation expense from operating income. Non-GAAP operating margin is the ratio calculated by dividing non-GAAP operating income by revenues.

These non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP and should not be considered as a substitute for, or superior to, GAAP results. The company cautions investors that non-GAAP financial information, by its nature, departs from traditional accounting conventions; accordingly, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. Whenever we use these non-GAAP financial measures, we provide a reconciliation of the applicable non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measures as detailed in the tables below.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding the company’s industry, business strategy, plans, goals and expectations concerning our market position, product expansion, future operations, revenue, margins, profitability, future efficiencies, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the control of the company. The company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, the continued availability of tax-advantaged consumer-directed benefits to employers and employees, the company’s ability to acquire and retain new network partners and to cross-sell its products to existing network partners and members, the company’s ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets, the company’s ability to raise awareness among employers and employees about the advantages of adopting and participating in consumer-directed benefits programs, and the company’s ability to identify and execute on network partner opportunities. For a detailed discussion of these and other risk factors, please refer to the risks detailed in the company’s filings with the Securities and Exchange Commission, including, without limitation, the most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. The company undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing the company’s views as of any date subsequent to the date of this press release.

HealthEquity, Inc. and its subsidiaries
Condensed consolidated statements of operations and comprehensive income (unaudited)
 
  Three months ended July 31, Six months ended July 31,
(in thousands, except per share data) 2015 2014 2015 2014
Revenue:        
Account fee revenue  $ 14,604  $ 10,548  $ 29,001  $ 20,936
Custodial fee revenue  9,031  5,934  17,450  11,361
Card fee revenue  6,771  4,233  13,588  8,531
Other revenue  88  176  305  294
Total revenue  30,494  20,891  60,344  41,122
Cost of services:        
Account costs  8,316  6,703  16,705  13,131
Custodial costs  1,512  1,006  2,935  1,944
Card costs  2,049  1,412  4,151  2,817
Other costs  32  1  62  2
Total cost of services  11,909  9,122  23,853  17,894
Gross profit  18,585  11,769  36,491  23,228
Operating expenses:        
Sales and marketing  2,737  2,321  5,570  4,554
Technology and development  3,998  2,302  7,522  4,488
General and administrative  3,943  1,666  7,101  2,809
Amortization of acquired intangible assets  409  409  818  818
Total operating expenses  11,087  6,698  21,011  12,669
Income from operations  7,498  5,071  15,480  10,559
Other expense:        
Loss on revaluation of redeemable convertible preferred stock derivative  —  —  —  (735)
Other expense, net  (542)  (39)  (647)  (131)
Total other expense  (542)  (39)  (647)  (866)
Income before income taxes  6,956  5,032  14,833  9,693
Income tax provision  2,535  2,004  5,435  3,947
Net income  $ 4,421  $ 3,028  $ 9,398  $ 5,746
Net income attributable to common stockholders:        
Basic  $ 4,421  $ 1,565  $ 9,398  $ 5,457
Diluted  $ 4,421  $ 2,591  $ 9,398  $ 6,481
Net income per share attributable to common stockholders:        
Basic  $ 0.08  $ 0.19  $ 0.17  $ 0.70
Diluted  $ 0.08  $ 0.06  $ 0.16  $ 0.14
Weighted-average number of shares used in computing net income per share attributable to common stockholders:        
Basic  56,730  8,135  55,909  7,757
Diluted  58,932  41,680  58,318  45,847
Comprehensive income:        
Net income  $ 4,421  $ 3,028  $ 9,398  $ 5,746
Other comprehensive loss:        
Unrealized loss on available-for-sale marketable securities, net of tax  (11)  —  (33)  —
Comprehensive income  $ 4,410  $ 3,028  $ 9,365  $ 5,746

Stock-based compensation expense

Total stock-based compensation expense included in the condensed consolidated statements of operations and comprehensive income is as follows:

 
  Three months ended July 31, Six months ended July 31,
(in thousands) 2015 2014 2015 2014
Cost of services  $ 208  $ 52  $ 436  $ 70
Sales and marketing  259  138  487  141
Technology and development  237  53  387  85
General and administrative  973  160  1,461  172
Total stock-based compensation expense  $ 1,677  $ 403  $ 2,771  $ 468
         

The following table presents components of our condensed consolidated statements of operations and comprehensive income, adjusted for stock compensation expense:

 
  Three months ended July 31, Six months ended July 31,
(in thousands, except for percentages) 2015 2014 2015 2014
Reconciliation of gross profit to non-GAAP gross profit:        
Gross profit  $ 18,585   $ 11,769   $ 36,491   $ 23,228 
Excluding: Stock-based compensation expense attributable to cost of services  208  52  436  70
Non-GAAP gross profit  $ 18,793  $ 11,821  $ 36,927  $ 23,298
Reconciliation of gross margin to non-GAAP gross margin:        
GAAP gross margin 61% 56% 60% 56%
Excluding: Stock-based compensation expense attributable to cost of services 1% —% 1% 1%
Non-GAAP gross margin 62% 56% 61% 57%
Reconciliation of income from operations to non-GAAP income from operations:        
Income from operations  $ 7,498  $ 5,071  $ 15,480  $ 10,559
Excluding: Stock-based compensation expense  1,677  403  2,771  468
Non-GAAP income from operations  $ 9,175  $ 5,474  $ 18,251  $ 11,027
Reconciliation of operating margin to non-GAAP operating margin:        
GAAP operating margin 25% 24% 26% 26%
Excluding: Stock-based compensation expense 5% 2% 4% 1%
Non-GAAP operating margin 30% 26% 30% 27%
         
Net income reconciliation to Adjusted EBITDA
 
  Three months ended July 31, Six months ended July 31,
(in thousands) 2015 2014 2015 2014
Net income  $ 4,421  $ 3,028  $ 9,398  $ 5,746
Income tax provision  2,535  2,004  5,435  3,947
Depreciation and amortization  1,506  983  2,847  1,825
Amortization of acquired intangible assets  409  409  818  818
Loss on revaluation of redeemable convertible preferred stock derivative liability  —  —  —  735
Stock-based compensation expense  1,677  403  2,771  468
Other (1)  544  40  647  132
Total adjustments  $ 6,671  $ 3,839  $ 12,518  $ 7,925
Adjusted EBITDA  $ 11,092  $ 6,867  $ 21,916  $ 13,671
         
(1)  For the three months ended July 31, 2015 and 2014, Other consisted of interest income of $(109) and $0, miscellaneous taxes of $82 and $40, and acquisition-related costs of $571 and $0, respectively. For the six months ended July 31, 2015 and 2014, Other consisted of interest income of $(185) and $0, miscellaneous taxes of $171 and $132, and acquisition-related costs of $661 and $0, respectively.
         
HSA Members
 
  July 31, 2015 July 31, 2014 % Change January 31, 2015
HSA Members  1,537,147  1,061,713 45%  1,426,785
Average HSA Members – Year-to-date  1,484,990  1,015,539 46%  1,087,962
Average HSA Members – Quarter-to-date  1,510,403  1,038,853 45%  1,230,256
         
Assets under management (AUM)
 
(in thousands, except percentages) July 31, 2015 July 31, 2014 % Change January 31, 2015
Cash AUM  $ 2,260,111  $ 1,546,753 46%  $ 2,075,741
Investment AUM  372,120  237,831 56%  286,526
Total AUM  $ 2,632,231  $ 1,784,584 47%  $ 2,362,267
Average daily cash AUM – Year-to-date  $ 2,176,971  $ 1,480,075 47%  $ 1,553,845
Average daily cash AUM – Quarter-to-date  $ 2,214,287  $ 1,500,672 48%  $ 1,698,402
         
Net income per diluted share reconciliation to Pro forma non-GAAP earnings per diluted share
 
  Three months ended July 31, Six months ended July 31,
(in thousands, except per share data) 2015 2014 2015 2014
Net income attributable to common stockholders for diluted earnings per share  $ 4,421  $ 2,591  $ 9,398  $ 6,481
GAAP adjustments for participating securities (1)  —  $ 437  —  $ (735)
Net income  $ 4,421  $ 3,028  $ 9,398  $ 5,746
Stock compensation expense, net of tax (2)  1,027  252  1,718  290
Adjusted net income  5,448  3,280  11,116  6,036
Pro forma diluted weighted-average number of shares used in computing pro forma non-GAAP earnings per diluted share (3)  58,932  46,137  58,318  45,923
Pro forma non-GAAP earnings per diluted share  $ 0.09  $ 0.07  $ 0.19  $ 0.13
         
(1) The net impact of adjustments required for participating securities in conformity with the two-class method as prescribed by GAAP.
(2) The company used an estimated statutory tax rate of 38% to calculate the net impact of non-cash stock-based compensation expense.
(3) For the three and six months ended July 31, 2014, the pro forma diluted weighted average shares outstanding give effect to the conversion of all outstanding shares of convertible preferred stock and redeemable preferred stock into 32,468 shares of common stock using the as-if converted method as of the beginning of the period. In August 2014, in connection with the closing of the Company’s initial public offering, all of the outstanding convertible preferred stock and redeemable convertible preferred stock were converted into common stock.
CONTACT: Investors Contact:
         Westwicke Partners
         Bob East / Asher Dewhurst
         443-213-0500
         healthequity@westwicke.com

Left Menu Icon
Right Menu Icon